Mitochondrial Coenzyme Q Protects Sepsis-Induced Acute Lung Injury by Activating PI3K/Akt/GSK-3β/mTOR Pathway in Rats

Mitochondrial Coenzyme Q Protects Sepsis-Induced Acute Lung Injury by Activating PI3K/Akt/GSK-3β/mTOR Pathway in Rats

The aim of our study was to assess the effects of mitochondrial coenzyme Q (MitoQ) on sepsis-induced acute lung injury (ALI) and investigate its possible mechanisms. The cecal ligation and puncture (CLP) method was used to establish a septic ALI model. Rats were randomly divided into Con group, CLP...

Full description

Bibliographic Details
Main Authors:	Ruirui Li, Tao Ren, Jianqiong Zeng
Format:	Article
Language:	English
Published:	Hindawi Limited 2019-01-01
Series:	BioMed Research International
Online Access:	http://dx.doi.org/10.1155/2019/5240898

Similar Items

Roles of PI3K/AKT/GSK3/mTOR Pathway in Cell Signaling of Mental Illnesses
by: Yasuko Kitagishi, et al.
Published: (2012-01-01)

PI3K/AKT/mTOR pathway in Angiogenesis
by: Jayashree eKarar, et al.
Published: (2011-12-01)

Tempol Protects Against Acute Renal Injury by Regulating PI3K/Akt/mTOR and GSK3β Signaling Cascades and Afferent Arteriolar Activity
by: Gensheng Zhang, et al.
Published: (2018-05-01)

Liraglutide Protects Nucleus Pulposus Cells Against High-Glucose Induced Apoptosis by Activating PI3K/Akt/ mTOR/Caspase-3 and PI3K/Akt/GSK3β/Caspase-3 Signaling Pathways
by: Mingyan Yao, et al.
Published: (2021-02-01)

Dehydrocostuslactone suppresses angiogenesis in vitro and in vivo through inhibition of Akt/GSK-3β and mTOR signaling pathways.
by: Chih-Ya Wang, et al.
Published: (2012-01-01)

PI3K/Akt/mTOR inhibitors in breast cancer
by: Joycelyn JX Lee, et al.
Published: (2015-12-01)

Targeting PI3K/Akt/mTOR Signaling In Cancer
by: Camillo ePorta, et al.
Published: (2014-04-01)

AKTivation of the PI3K/AKT/mTOR signaling pathway by KSHV
by: Aadra P Bhatt, et al.
Published: (2013-01-01)

The Role of PI3K/Akt/mTOR Signaling in Gastric Carcinoma
by: Tasuku Matsuoka, et al.
Published: (2014-07-01)

Synthesis and evaluation of novel PI3-K-Akt-mTOR modulators
by: Gunn, Richard Martin
Published: (2010)

Baicalin attenuated substantia nigra neuronal apoptosis in Parkinson's disease rats via the mTOR/AKT/GSK-3β pathway
by: Heng Zhai, et al.
Published: (2019-12-01)

Sinularin by inactivating mitochondrial and inhibition of PI3K/AKT/mTOR pathway induces apoptosis in gastric cancer.
by: Shu-Hao Yeh, et al.
Published: (2015)

Targeting PI3K/AKT/mTOR Signaling Pathway in Breast Cancer
by: Huayi Li, et al.
Published: (2021-07-01)

Targeting PI3K/Akt/mTOR in AML: Rationale and Clinical Evidence
by: Salihanur Darici, et al.
Published: (2020-09-01)

Targeting the PI3K/Akt/mTOR signalling pathway in Cystic Fibrosis
by: R. Reilly, et al.
Published: (2017-08-01)

The PI3K/AKT/mTOR signaling pathway is overactivated in primary aldosteronism.
by: Hengchuan Su, et al.
Published: (2013-01-01)

Therapeutic targets for cancer: Current concepts with PI 3-K, Akt, & mTOR
by: Kenneth Maiese
Published: (2013-01-01)

PI3K/Akt/mTOR signaling pathway and malignant hepatobiliary tumors
by: CHEN Xuxiao
Published: (2015-06-01)

Targeting the PI3K/Akt/mTOR Signaling Pathway: Applications of Nanotechnology
by: Forough Alemi Serej, et al.
Published: (2018-01-01)

Role of PI3K/Akt/mTOR signaling pathway in hepatocellular carcinoma
by: YU Yuan
Published: (2014-09-01)

Targeting of the PI3K/AKT/mTOR pathway in human prostate cancer
by: Butler, Dominika Ewelina
Published: (2014)

Targeting the Hedgehog and PI3K/AKT/mTOR signaling pathways in rhabdomyosarcoma
by: Geyer, Natalie
Published: (2018)

Carcinoma da bexiga: via de sinalização PI3K/Akt/mTOR e inibidores do mTOR
by: Maria do Céu dos Santos Silva Costa
Published: (2019)

Coenzyme Q10 Inhibits the Aging of Mesenchymal Stem Cells Induced by D-Galactose through Akt/mTOR Signaling
by: Dayong Zhang, et al.
Published: (2015-01-01)

The PI3K/AKT/mTOR pathway in breast cancer: targets, trials and biomarkers
by: Elisavet Paplomata, et al.
Published: (2014-07-01)

Research Progress on PI3K/AKT/mTOR Signaling Pathway in Burkitt Lymphoma
by: SUN Yuanyuan, et al.
Published: (2019-02-01)

Roles of the PI3K/AKT/mTOR signalling pathways in neurodegenerative diseases and tumours
by: Fei Xu, et al.
Published: (2020-04-01)

Sequential dosing in chemosensitization: targeting the PI3K/Akt/mTOR pathway in neuroblastoma.
by: Mike-Andrew Westhoff, et al.
Published: (2013-01-01)

Cyclophosphamide Inhibits PI3K/AKT/mTOR Signaling Pathway in Mice Kidneys
by: Gulsah Albayrak, et al.
Published: (2018-12-01)

Inhibitors of the PI3K/Akt/mTOR Pathway in Prostate Cancer Chemoprevention and Intervention
by: Nazanin Momeni Roudsari, et al.
Published: (2021-08-01)

Rhaponticin suppresses osteosarcoma through the inhibition of PI3K-Akt-mTOR pathway
by: Suresh Mickymaray, et al.
Published: (2021-07-01)

Strophanthidin Attenuates MAPK, PI3K/AKT/mTOR, and Wnt/β-Catenin Signaling Pathways in Human Cancers
by: Dhanasekhar Reddy, et al.
Published: (2020-01-01)

The PI3K-Akt-mTOR pathway regulates Aβ oligomer induced neuronal cell cycle events
by: Herrup Karl, et al.
Published: (2009-03-01)

Allosteric modulation of Ras and the PI3K/AKT/mTOR pathway: Emerging Therapeutic Opportunities
by: Paul A Hubbard, et al.
Published: (2014-12-01)

Oxidant Stress and Signal Transduction in the Nervous System with the PI 3-K, Akt, and mTOR Cascade
by: Yan Chen Shang, et al.
Published: (2012-10-01)

Signal Transduction Pathways in Breast Cancer: The Important Role of PI3K/Akt/mTOR
by: Miguel A. Ortega, et al.
Published: (2020-01-01)

PI3K/Akt/mTOR Signaling Pathway and Non-small Cell Lung Cancer
by: Huiwei QI, et al.
Published: (2010-12-01)

Inhibition of the PI3K-Akt-mTOR signaling pathway in T lymphocytes in patients with active tuberculosis
by: XueXuan Zhang, et al.
Published: (2017-06-01)

PIM Kinases and Their Relevance to the PI3K/AKT/mTOR Pathway in the Regulation of Ovarian Cancer
by: Aziz Ur Rehman Aziz, et al.
Published: (2018-02-01)

The Roles of PI3K/AKT/mTOR and MAPK/ERK Signaling Pathways in Human Pheochromocytomas
by: Juan Du, et al.
Published: (2016-01-01)